Levi & Korsinsky appointed Co-Lead Counsel Amla Litigation

On March 8, 2017, Levi & Korsinsky, LLP was appointed to serve as Co-Lead Counsel by Judge Jed S. Rakoff in the consolidated class action entitled In re: Amla Litig., Case No. 1:16-cv-06593 (S.D.N.Y).  This is a consumer class action against L'Oreal U.S.A., Inc. and SoftSheen Carson LLC pending in the Southern District of New York.  Levi & Korsinsky represents Plaintiffs Sharon Manier and Dorothy Riles in the consolidated action (Case No. 17-cv-111) (JSR). L’Oréal U.S.A. is the world's largest cosmetics company and has developed activities in the field of cosmetics, concentrating on hair color, skin care, sun protection, make-up, perfume and hair care. In 1998, L’Orèal acquired Soft-Sheen Products Inc., making the company a leading manufacturer in marketing and selling beauty products to consumers of hair relaxers. The class action alleges that Defendants misrepresented the qualities and capabilities of its Amla hair relaxer and, further, that the Amla hair relaxer is not safe or effective as a hair relaxer even when used as directed.  It is also alleges that Defendants falsely market Amla as an oil-based product that can nourish and condition the scalp with vitamins and minerals. Defendants moved to dismiss the claims plead in In re Amla Litig., and in the Manier action. Judge Rakoff largely sustained the claims plead in both actions with leave to replead.  A Consolidated Amended Complaint will be filed by the newly-appointed Co-Lead Counsel. Levi & Korsinsky attorneys, Lori G. Feldman and Andrea Clisura, diligently devoted themselves to obtaining Co-Lead Counsel on this case, and did so successfully. Notably, Levi & Korsinsky’s motion was contested by a competing motion made by three different law firms. The competing motion was supported by eight additional law firms, but was denied by Judge Rakoff. The Levi & Korsinsky team looks forward to vigorously litigating this case with its Co-Lead Counsel, Geragos & Geragos APC, on behalf of all consumers harmed by L’Oréal U.S.A., Inc. and SoftSheen Carson LLC. Copies of the Memorandum Order dated March 8, 2017 can be found here.